DE3262800D1 - Renally active dipeptides - Google Patents

Renally active dipeptides

Info

Publication number
DE3262800D1
DE3262800D1 DE8282304702T DE3262800T DE3262800D1 DE 3262800 D1 DE3262800 D1 DE 3262800D1 DE 8282304702 T DE8282304702 T DE 8282304702T DE 3262800 T DE3262800 T DE 3262800T DE 3262800 D1 DE3262800 D1 DE 3262800D1
Authority
DE
Germany
Prior art keywords
renally
dipeptides
active dipeptides
alpha
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282304702T
Other languages
English (en)
Inventor
Francis Richard Pfeiffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE3262800D1 publication Critical patent/DE3262800D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
DE8282304702T 1981-09-09 1982-09-08 Renally active dipeptides Expired DE3262800D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/300,546 US4395401A (en) 1981-09-09 1981-09-09 Renally active dipeptides

Publications (1)

Publication Number Publication Date
DE3262800D1 true DE3262800D1 (en) 1985-05-02

Family

ID=23159558

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282304702T Expired DE3262800D1 (en) 1981-09-09 1982-09-08 Renally active dipeptides

Country Status (10)

Country Link
US (1) US4395401A (de)
EP (1) EP0074787B1 (de)
JP (1) JPS5874649A (de)
AT (1) ATE12349T1 (de)
AU (1) AU549457B2 (de)
DE (1) DE3262800D1 (de)
DK (1) DK362082A (de)
GR (1) GR76703B (de)
IE (1) IE54226B1 (de)
ZA (1) ZA825331B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
JPS62114957A (ja) * 1985-11-13 1987-05-26 Suntory Ltd プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジン誘導体およびその製法並びに用途
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
GB9023116D0 (en) * 1990-10-24 1990-12-05 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
EP0728145A1 (de) * 1993-11-01 1996-08-28 Ciba-Geigy Japan Limited Endothelin rezeptor antagoniste
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
AU7246398A (en) * 1997-04-30 1998-11-24 Northwestern University Inhibition of nitric oxide synthase by amino acids and dipeptides
AU759022B2 (en) * 1999-02-18 2003-04-03 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527932C2 (de) * 1974-07-02 1983-04-21 Pentapharm AG, 4052 Basel Säureadditionssalze von Tripeptidderivaten und deren Verwendung als Substrate zur Bestimmung von Plasmakallikrein

Also Published As

Publication number Publication date
EP0074787A1 (de) 1983-03-23
ATE12349T1 (de) 1985-04-15
AU549457B2 (en) 1986-01-30
DK362082A (da) 1983-03-10
IE822182L (en) 1983-03-09
IE54226B1 (en) 1989-07-19
GR76703B (de) 1984-08-29
JPS5874649A (ja) 1983-05-06
AU8645482A (en) 1983-03-17
EP0074787B1 (de) 1985-03-27
ZA825331B (en) 1983-06-29
US4395401A (en) 1983-07-26

Similar Documents

Publication Publication Date Title
DE3262800D1 (en) Renally active dipeptides
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
BG38487A3 (en) Method for preparing peptides
UA6041A1 (uk) СПОСІБ ОДЕРЖАННЯ СПОЛУЧЕНЬ beta-ЛАКТАМА
FI860285A (fi) 6-tioxantinderivat.
AU600907B2 (en) Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use
AU546158B2 (en) Cycloaliphatic pharmaceutical compounds
DE3873454D1 (de) Befestigungsweise eines dichtungsprofils.
ES515070A0 (es) "un conjunto de cuchilla distribuidora".
DE69006931D1 (de) Ghilanten: antimetastatischer Wirkstoff aus dem südamerikanischen Blutegel Haementeria Ghilianii.
ES516001A0 (es) "procedimiento de hidrogenolisis de un polialcohilenglicol".
GB1434139A (en) 3-substituted-4-hydroxyphenyl-2-piperidylcarbinols
ES8401951A1 (es) Un procedimiento para la preparacion de derivados de bencenosulfonamidas.
ES516000A0 (es) "procedimiento de hidrogenolisis de un polialcohilenglicol".
FR2411170A1 (fr) Procede de preparation de chlorure de pentachlorovinylacetyle
GB1390650A (en) Oxazines and thiazines
GB1395929A (en) Thioureas
ES512564A0 (es) "un procedimiento para la preparacion enantioselectiva de derivados n-sustituidos de prolina".
JPS56166158A (en) Novel benzyloxycarbonyl-leucyl-leucyl-valyl-4-amino-3- hydroxy-6-methyl-heptanoyl-alanine and its preparation
IT1222513B (it) Analoghi di 7 ossabiciclo (2.2.1) eptano
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят
IT1226430B (it) Difluoroalometossifenil-derivato e miticida che contiene detto derivato come ingrediente attivo
GR65646B (en) Aminoderivatives of 2-methylo-5(2-hydroxistirolo)1,3,4-thiazole
IL67357A0 (en) Preparation of cyclic 1,2-cis-diols from cyclic 1,2-epoxides
IT7823549A0 (it) Composto di pentapeptide adattivita' analgesica.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee